Do physicians' perceptions of drug costs influence their prescribing?

PharmacoEconomics

Volumn 9, Issue 4, 1996, Pages 321-331

  Ryan, Mandy ^a   Yule, Brian ^a   Bond, Christine ^a   Taylor, Ross J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CIMETIDINE; CODYDRAMOL; DEXTROPROPOXYPHENE PLUS PARACETAMOL; PARACETAMOL; PENICILLIN DERIVATIVE; PENICILLIN G; RANITIDINE;

ARTICLE; CONTROLLED STUDY; DRUG COST; HUMAN; NORMAL HUMAN; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0029918536     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199609040-00005     Document Type: Article

References (37)

1. Office of Health Economics Compendium of Health Statistics. London: Office of Health Economics, 1994
2. Yule B, Fordyce I, Bond C, et al. The 'limited list' in general practice: implications for the costs and effectiveness of prescribing. Health Economics Research Unit Discussion Paper No. 01/88. Aberdeen: University of Aberdeen, 1988
3. Harris CM, Heywood PL, Clayden AD. The analysis of prescribing in general practice. London: Her Majesty's Stationery Office, 1990
4. Scottish Home and Health Department. Introducing Scottish prescribing analysis. Edinburgh: Her Majesty's Stationery Office, 1990
5. Secretaries of State for Health, Wales, Northern Ireland and Scotland. Working for patients (Cm 555). London: Her Majesty's Stationery Office, 1989
6. Lowkes FGR. Doctors' knowledge of the costs of medical care. Med Educ 1985; 19: 113-7
7. Rowe J, MacVicar S. Doctors' knowledge of the cost of common medications. J Clin Hosp Phartn 1986; 11: 365-8
8. Ryan M, Yule B, Bond C, et al. Scottish general practitioners' attitudes and knowledge in respect of prescribing costs. BMJ 1990; 300: 1316-8
9. Ryan M, Yule B, Bond C, et al. Knowledge of drug costs: a comparison of general practitioners in England and Scotland. Br J Gen Pract 1992; 42: 6-9
10. Lowy DR, Lowy L, Warner RS. A survey of physicians' awareness of drug costs. J Med Educ 1972; 147: 349-51
11. Nagurney JT, Braham RL, Reader GG, et al. Physician awareness of economic factors in clinical decision-making. Med Care 1979; 17 (7): 727-36
12. Thomas DR, Davis KM. Physician awareness of cost under prospective reimbursement systems. Med Care 1987; 25: 181-4
13. Hershey CO, Porter DK, Breslau D, et al. Influence of simple computerized feedback on prescription charges in an ambulatory clinic: a randomized clinical trial. Med Care 1986; 24: 472-81
14. Zelnio RN, Gagnon JP. The effects of price information on physician prescribing patterns: a literature review. Drug Intell Clin Pharm 1979; 13: 156-9
15. Oppenheim GL, Erickson SH, Ashworth C. The family physician's knowledge of the price of prescribed drugs. J Fam Pract 1981; 12: 1027-30
16. Glickman L, Bruce K, Caro H, et al. Physician's knowledge of drug costs for the elderly. J Am Geriatr Soc 1991; 42: 992-6
17. Skipper J, Smoth G, Mulligan J, et al. Physicians' knowledge of cost: the case of diagnostic tests. Inquiry 1976; 3: 194-8
18. Long MJ, Cummings M, Frisof KB. The role of perceived price in physicians' demand for diagnostic tests. Med Care 1983; 21: 243-50
19. Reekie WD. Price sensitivity of general practitioners. In: Phillips CI, Wolfe JN, editors. Clinical practice and economics. Bath: Pitman, 1977: 169-84
20. Denig P, Haaijer-Ruskamp FM. Do physicians take cost into account when making prescribing decisions? Pharmaco-Economics 1995; 8 (4): 282-90
21. Segal R, Helper CD. Prescribers' beliefs and values as predictors of drug choices. Am J Hosp Pharm 1982; 39: 1391-7
22. Zelnio RN. The interaction among the criteria physicians use when prescribing. Med Care 1982; 20: 277-85
23. Denig P, Haaijer-Ruskamp FM, Zijsling DH. How physicians choose drugs. Soc Sci Med 1988; 27: 1381-6
24. Janknegt R, Steenhoek A. Keuzecriteria voor geneesmiddelen bij een 'eenvoudige cystitis'. Tijdschr Ther Geneesm Onderz 1988; 13: 204-8
25. Janknegt R, Smelik J, Steenhoek A. Betablokkers: keuzecriteria en produktvoorkeur Resultaten van een onderzoek bij vijftig artsen. Pharm Weekbl 1990; 125: 676-80
26. Miller RR. Prescribing habits of physicians: a review of studies on prescribing of drugs. Drug Intell Clin Pharm 1973; 7: 560-4
27. Caplow T, Raymond JJ. Factors influencing the selection of pharmaceutical products. J Market 1984; 19: 18-9
28. Epstein AM, Read JL, Winickoff R. Physician beliefs, attitudes and prescribing behaviour for anti-inflammatory drugs. Am J Med 1984; 77: 313-8
29. Segal R, Hepler CD. Drug choice as a problem solving process. Med Care 1985; 23: 967-76
30. Chinburapa V, Larson LN. Predicting prescribing intention and assessing drug attribute importance using conjoint analysis. J Pharm Mark Manage 1988; 2: 3-18
31. Chinburapa V, Larson LN. The importance of side effects and outcomes in differentiating between prescription drug products. J Clin Pharm Ther 1992; 17: 333-42
32. Denig P, Haaijer-Ruskamp FM, Wesseling H, et al. Towards understanding treatment preferences of hospital physicians. Soc Sci Med 1993; 36: 915-24
33. Taylor RJ, Bond CM. Change in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice. Br J Gen Pract 1991; 41: 244-8
34. Robertson WO. Costs of diagnostic tests: estimates by health professionals. Med Care 1980; 10: 556-9
35. British National Formulary. London: British Medical Association/Royal Pharmaceutical Society of Great Britain, 1990 Mar
36. Rosett RN, Nelson FD. Estimation of the two-limit probit regression model. Econometrica 1975; 43: 141-6
37. Maddala GS. Limited-dependent and qualitative variables in econometrics. Cambridge: Cambridge University Press, 1983